155 related articles for article (PubMed ID: 24639469)
1. Potential biomarker of metformin action.
He L; Meng S; Germain-Lee EL; Radovick S; Wondisford FE
J Endocrinol; 2014 Jun; 221(3):363-9. PubMed ID: 24639469
[TBL] [Abstract][Full Text] [Related]
2. Metformin and insulin suppress hepatic gluconeogenesis through phosphorylation of CREB binding protein.
He L; Sabet A; Djedjos S; Miller R; Sun X; Hussain MA; Radovick S; Wondisford FE
Cell; 2009 May; 137(4):635-46. PubMed ID: 19450513
[TBL] [Abstract][Full Text] [Related]
3. Metformin suppresses hepatic gluconeogenesis and lowers fasting blood glucose levels through reactive nitrogen species in mice.
Fujita Y; Hosokawa M; Fujimoto S; Mukai E; Abudukadier A; Obara A; Ogura M; Nakamura Y; Toyoda K; Nagashima K; Seino Y; Inagaki N
Diabetologia; 2010 Jul; 53(7):1472-81. PubMed ID: 20349346
[TBL] [Abstract][Full Text] [Related]
4. Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state.
Foretz M; Hébrard S; Leclerc J; Zarrinpashneh E; Soty M; Mithieux G; Sakamoto K; Andreelli F; Viollet B
J Clin Invest; 2010 Jul; 120(7):2355-69. PubMed ID: 20577053
[TBL] [Abstract][Full Text] [Related]
5. PPP1R3C mediates metformin-inhibited hepatic gluconeogenesis.
Ji X; Wang S; Tang H; Zhang Y; Zhou F; Zhang L; Zhu Q; Zhu K; Liu Q; Liu Y; Wang X; Zhou L
Metabolism; 2019 Sep; 98():62-75. PubMed ID: 31181215
[TBL] [Abstract][Full Text] [Related]
6. Low concentrations of metformin suppress glucose production in hepatocytes through AMP-activated protein kinase (AMPK).
Cao J; Meng S; Chang E; Beckwith-Fickas K; Xiong L; Cole RN; Radovick S; Wondisford FE; He L
J Biol Chem; 2014 Jul; 289(30):20435-46. PubMed ID: 24928508
[TBL] [Abstract][Full Text] [Related]
7. Role of KLF15 in regulation of hepatic gluconeogenesis and metformin action.
Takashima M; Ogawa W; Hayashi K; Inoue H; Kinoshita S; Okamoto Y; Sakaue H; Wataoka Y; Emi A; Senga Y; Matsuki Y; Watanabe E; Hiramatsu R; Kasuga M
Diabetes; 2010 Jul; 59(7):1608-15. PubMed ID: 20393151
[TBL] [Abstract][Full Text] [Related]
8. The importance of the AMPK gamma 1 subunit in metformin suppression of liver glucose production.
An H; Wang Y; Qin C; Li M; Maheshwari A; He L
Sci Rep; 2020 Jun; 10(1):10482. PubMed ID: 32591547
[TBL] [Abstract][Full Text] [Related]
9. Metformin primarily decreases plasma glucose not by gluconeogenesis suppression but by activating glucose utilization in a non-obese type 2 diabetes Goto-Kakizaki rats.
Yoshida T; Okuno A; Tanaka J; Takahashi K; Nakashima R; Kanda S; Ogawa J; Hagisawa Y; Fujiwara T
Eur J Pharmacol; 2009 Nov; 623(1-3):141-7. PubMed ID: 19765581
[TBL] [Abstract][Full Text] [Related]
10. Effects of metformin on glucose and glucagon regulated gluconeogenesis in cultured normal and diabetic hepatocytes.
Yu B; Pugazhenthi S; Khandelwal RL
Biochem Pharmacol; 1994 Aug; 48(5):949-54. PubMed ID: 8093107
[TBL] [Abstract][Full Text] [Related]
11. Regulation of hepatic gluconeogenesis by nuclear factor Y transcription factor in mice.
Zhang Y; Guan Q; Liu Y; Zhang Y; Chen Y; Chen J; Liu Y; Su Z
J Biol Chem; 2018 May; 293(20):7894-7904. PubMed ID: 29530977
[TBL] [Abstract][Full Text] [Related]
12. Effect of metformin on fatty acid and glucose metabolism in freshly isolated hepatocytes and on specific gene expression in cultured hepatocytes.
Fulgencio JP; Kohl C; Girard J; Pégorier JP
Biochem Pharmacol; 2001 Aug; 62(4):439-46. PubMed ID: 11448453
[TBL] [Abstract][Full Text] [Related]
13. Metformin activates AMP-activated protein kinase by promoting formation of the αβγ heterotrimeric complex.
Meng S; Cao J; He Q; Xiong L; Chang E; Radovick S; Wondisford FE; He L
J Biol Chem; 2015 Feb; 290(6):3793-802. PubMed ID: 25538235
[TBL] [Abstract][Full Text] [Related]
14. Low metformin causes a more oxidized mitochondrial NADH/NAD redox state in hepatocytes and inhibits gluconeogenesis by a redox-independent mechanism.
Alshawi A; Agius L
J Biol Chem; 2019 Feb; 294(8):2839-2853. PubMed ID: 30591586
[TBL] [Abstract][Full Text] [Related]
15. Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP.
Kim YD; Park KG; Lee YS; Park YY; Kim DK; Nedumaran B; Jang WG; Cho WJ; Ha J; Lee IK; Lee CH; Choi HS
Diabetes; 2008 Feb; 57(2):306-14. PubMed ID: 17909097
[TBL] [Abstract][Full Text] [Related]
16. Dysregulated expression of monoacylglycerol lipase is a marker for anti-diabetic drug metformin-targeted therapy to correct impaired neurogenesis and spatial memory in Alzheimer's disease.
Syal C; Kosaraju J; Hamilton L; Aumont A; Chu A; Sarma SN; Thomas J; Seegobin M; Dilworth FJ; He L; Wondisford FE; Zimmermann R; Parent M; Fernandes K; Wang J
Theranostics; 2020; 10(14):6337-6360. PubMed ID: 32483456
[No Abstract] [Full Text] [Related]
17. Metformin inhibits glycogen synthesis and gluconeogenesis in cultured rat hepatocytes.
Otto M; Breinholt J; Westergaard N
Diabetes Obes Metab; 2003 May; 5(3):189-94. PubMed ID: 12681026
[TBL] [Abstract][Full Text] [Related]
18. Berberine inhibits hepatic gluconeogenesis via the LKB1-AMPK-TORC2 signaling pathway in streptozotocin-induced diabetic rats.
Jiang SJ; Dong H; Li JB; Xu LJ; Zou X; Wang KF; Lu FE; Yi P
World J Gastroenterol; 2015 Jul; 21(25):7777-85. PubMed ID: 26167077
[TBL] [Abstract][Full Text] [Related]
19. Molecular action of metformin in hepatocytes: an updated insight.
Sliwinska A; Drzewoski J
Curr Diabetes Rev; 2015; 11(3):175-81. PubMed ID: 25808533
[TBL] [Abstract][Full Text] [Related]
20. Activation of the cAMP-PKA pathway Antagonizes Metformin Suppression of Hepatic Glucose Production.
He L; Chang E; Peng J; An H; McMillin SM; Radovick S; Stratakis CA; Wondisford FE
J Biol Chem; 2016 May; 291(20):10562-70. PubMed ID: 27002150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]